YVONNE WAMBAA: Open Payments
NPI 1154092716 · HUNT VALLEY, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$256 in 11 payments from 5 companies in 2025. Trend: 2023 $0 · 2024 $80 · 2025 $256
Food & beverage: $256
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 3 | $73 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $48 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $47 |
| Alkermes, Inc. | 2 | $45 |
| Supernus Pharmaceuticals, Inc. | 2 | $43 |
Products named: COBENFY, CAPLYTA, TRINTELLIX, ARISTADA, Qelbree.
Industry payments across MD — which companies pay providers there.
